Jacobs Levy Equity Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Jacobs Levy Equity Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,550	Closed	-$73K	–	943
2017 Q1	$73K	Hold	10,550	–	–	﹤0.01%	881
2016 Q4	$58K	Sell	10,550 -900	-8%	-$4.69K	﹤0.01%	932
2016 Q3	$57K	Sell	11,450 -2,600	-19%	-$12.2K	﹤0.01%	989
2016 Q2	$63K	Hold	14,050	–	–	﹤0.01%	1118
2016 Q1	$63K	Sell	14,050 -7,610	-35%	-$36.3K	﹤0.01%	1059
2015 Q4	$114K	Sell	21,660 -2,300	-10%	-$13.1K	﹤0.01%	733
2015 Q3	$138K	Hold	23,960	–	–	﹤0.01%	738
2015 Q2	$171K	Sell	23,960 -10,300	-30%	-$71.6K	﹤0.01%	740
2015 Q1	$228K	Sell	34,260 -9,200	-21%	-$57.4K	﹤0.01%	683
2014 Q4	$260K	Sell	43,460 -1,900	-4%	-$9.75K	﹤0.01%	709
2014 Q3	$224K	Sell	45,360 -2,650	-6%	-$12.8K	﹤0.01%	728
2014 Q2	$216K	Buy	48,010 +4,000	+9%	+$17.9K	﹤0.01%	754
2014 Q1	$198K	Buy	+44,010	New	+$209K	﹤0.01%	824

Other funds holding CPIX

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jacobs Levy Equity Management's CPIX Position: Q2 2017 in Review

Jacobs Levy Equity Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2017, closing a stake of 10,550 shares — an estimated $73K sold.

Jacobs Levy Equity Management first reported a position in CPIX in Q1 2014 and held it in 13 quarters. The position peaked at $260K in Q4 2014. 34 funds tracked by Wall St. Rank hold CPIX as of Q2 2017.

Jacobs Levy Equity Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Jacobs Levy Equity Management sold 10,550 Cumberland Pharmaceuticals shares in Q2 2017, an estimated $73K.
Jacobs Levy Equity Management first reported a position in Cumberland Pharmaceuticals in Q1 2014 and held it in 13 quarters.
Jacobs Levy Equity Management's Cumberland Pharmaceuticals position peaked at $260K in Q4 2014.
34 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.